Shazia Sofi - Publications

Targeting the JAK/STAT signalling axis in cancer: chemopreventive potential of natural compounds with emerging focus on retinoids.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: May 12, 2026

Adapalene inhibits the activity of CD44, a cancer stem cell biomarker in Triple negative breast cancer.

Journal: Molecular biology reports

Published: March 23, 2026

Expression and potential role of ATP5F1A in breast cancer through an integrated in silico and in vitro approach.

Journal: In silico pharmacology

Published: January 15, 2026

Unravelling the p53 misfolding by chaperones in cancer.

Journal: Advances in protein chemistry and structural biology

Published: November 27, 2025

Cytochrome c as a central regulator of mitochondrial function in cancer metabolism.

Journal: Discover oncology

Published: September 15, 2025

Correction to: Balancing senescence and apoptosis: therapeutic insights into aging and cancer.

Journal: Molecular and cellular biochemistry

Published: September 13, 2025

Combating chemoresistance in breast cancer: exploring tumour microenvironment, combination therapies and drug repurposing strategies.

Journal: Journal of drug targeting

Published: August 21, 2025

Balancing senescence and apoptosis: therapeutic insights into aging and cancer.

Journal: Molecular and cellular biochemistry

Published: April 29, 2025

An update on cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer.

Journal: Future oncology (London, England)

Published: February 12, 2025

Unravelling the therapeutic potential of dual TGFβ-1 and CXCR4 inhibition in breast cancer using computational strategies.

Journal: PloS one

Published: January 13, 2025

Corrigendum: Targeting p53 misfolding conundrum by stabilizing agents and their analogues in breast cancer therapy: a comprehensive computational analysis.

Journal: Frontiers in pharmacology

Published: September 10, 2024

Targeting mutant p53: a key player in breast cancer pathogenesis and beyond.

Journal: Cell communication and signaling : CCS

Published: March 14, 2024